In non‐alcoholic fatty liver disease, the mitochondrial pyruvate carrier (MPC1) suppression alters hepatocyte lactate levels and modifies lactylation patterns of multiple proteins, with fatty acid synthase (FASN) being most prominently affected. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.